RIGEL PHARMACEUTICALS, INC. Active Patents
115 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-03-15: Application 18606346; Invention RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION; Applicant Rigel Pharmaceuticals, Inc.; Status Patented Case.
- 2024-01-25: Application 18422258; Invention INHIBITORS OF RET; Applicant Rigel Pharmaceuticals, Inc.; Status Patented Case.
- 2023-08-24: Application 18237824; Invention PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/; Applicant Rigel Pharmaceuticals, Inc.; Status Patented Case.
- 2023-04-26: Application 18307181; Invention RIP1K INHIBITORS; Applicant Rigel Pharmaceuticals, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-15 | 18606346 | RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION | Rigel Pharmaceuticals, Inc. | Patented Case | 2026-02-03 | 12539303 | US20250041297A1 | Erica Evans Raab Beni B. Wolf | United States United States | LEE, ANDREW P |
| 2024-01-25 | 18422258 | INHIBITORS OF RET | Rigel Pharmaceuticals, Inc. | Patented Case | 2026-06-16 | 12655128 | US20240417386A1 | Jason D. Brubaker Joseph L. Kim Kevin J. Wilson Douglas Wilson Lucian V. DiPietro | United States United States United States United States United States | MCDOWELL, BRIAN E |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |